Acadian Asset Management
OMED

Acadian Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Acadian Asset Management’s Portfolio OMED Stock Details OMED Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
2019
Q1 		$252K Buy
2018
Q4 		$146K Buy
2018
Q3 		$329K Buy
2018
Q2 		$320K Buy
2018
Q1 		$181K Buy
2017
Q2 		– Sell
2017
Q1 		$289K Buy